Harmony Biosciences Holdings, Inc. (HRMY) at a glance

Harmony Biosciences Holdings, Inc. (HRMY) is a small-cap Healthcare company. It trades at $39.14, with a P/E of 13.9, a 16.2% profit margin and revenue growth of 16.6%. It does not pay a dividend. Vestovix scores it 58/100 overall. Its strongest dimension is Value (87/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$39.14

Market cap

$1.99B

P/E ratio

13.9

Dividend yield

None

Beta

0.97

52-week range

$25.52 to $40.87